MiR-221/222 contained in exosomes released by tamoxifen-resistant breast cancer cells inhibits the expression of p27 and estrogen receptor (ER)-α, conferring tamoxifen resistance in target cells [28]. Here, ESR1 is linked to breast carcinoma.